RadNet, Inc. (RDNT)
SobrevaloradaFundamental
25
Precio
$68.81
Capitalización Bursátil
$5.43B
Parte 1 · Cuánto vale la empresa
Resumen
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance y Liquidez
Ingresos
$2.27B
Últimos 12 meses (hasta 30/6/2026)
Beneficio Neto
$-21M
Últimos 12 meses (hasta 30/6/2026)
Flujo de Caja Libre
-
Patrimonio Neto Total
$1.09B
Pasivo Total
$2.40B
Ratio de Liquidez
1.48
Cobertura de Intereses
0.99
Deuda/EBITDA
10.20
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$53.26
Precio Actual
$68.81
Margen de Seguridad
-29.2%
Rango de Valor Justo
$34.62 - $71.90
Dispersión entre los métodos de valoración utilizados, no un intervalo de confianza calibrado estadísticamente.
Métodos de Estimación
Métricas de Valoración
Ratio P/E
-
ROE
-1.7%
Ratio P/B
4.95
P/FCF
-
Margen Bruto
-
ROIC
1.6%
Radar de Rentabilidad
Creación de Valor (Ventaja Competitiva)
ROIC
1.6%
WACC
9.6%
ROIC − WACC
-8.1 pp
El ROIC está por debajo del coste del capital: la empresa destruye valor por cada dólar invertido.
Criterios de Análisis Fundamental
Superado (6)
- Price CAGR 27.50%
- Debt/Equity ratio
- Current Ratio
- Revenue Growth 5Y 13.7%
- Analyst Consensus 93% Buy
- Earnings Surprise avg 3.7%
Fallido (13)
- EPS shows upward trend
- ROIC 1.6%
- P/B Ratio 4.95
- Operating Margin 3.1%
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- DCF valuation (Overvalued)
- ROE -1.9%
- Share Dilution 6.8%
- Net Margin Trend -0.9% vs -0.8%
- Piotroski F-Score 3/9
No disponible (8)
- Gross Margin NaN%
- P/FCF NaN
- Dividend Payout NaN%
- Positive Free Cash Flow
- CapEx intensity
- Price below Graham Number
- PEG Ratio (need PE > 0 and growth > 0)
- Earnings Quality (OCF/Net Income)
Piotroski F-Score
Preocupaciones financieras graves
Calidad de los Beneficios
Baja calidad: investigue la contabilidad
Dilución de Acciones
Emitiendo nuevas acciones, diluyendo la participación
Participaciones institucionales
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Dr. Howard G. Berger M.D. | Chairman, President & CEO | 79 |
| Mr. Mark D. Stolper | Executive VP & CFO | 54 |
| Mr. Mital Patel | Executive VP & COO | 39 |
| Mr. Norman R. Hames | President & CEO of Western Operations | 69 |
| Mr. Stephen M. Forthuber | President & CEO of Eastern Operations | 64 |
| Dr. Alma Gregory Sorensen M.D. | Executive VP, Chief Strategy Officer & Director | 63 |
| Ms. Susan Hollabaugh | Chief Information Officer | - |
| Mr. David Jeffrey Katz Esq. | Executive VP, Chief Legal Officer & Corporate Secretary | 61 |
| Mr. David Manheim | Senior VP & Chief Compliance Officer | - |
| Mr. Michael M. Murdock | Executive Vice President of Mergers & Acquisitions | 70 |
Riesgo de Auditoría
8
Riesgo del Consejo
8
Riesgo de Compensación
7
Riesgo de Derechos del Accionista
2
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Documentos
- Ver documento
Informe anual (10-K)
Un resumen anual del negocio, los resultados financieros y los riesgos de la empresa.
Presentado el 2026-03-02
- Ver documento
Informe trimestral (10-Q)
Una actualización del desempeño financiero de los últimos tres meses.
Presentado el 2026-08-10
- Ver documento
Informe de hecho relevante (8-K)
Un aviso sobre un hecho relevante, como un cambio de dirección o un anuncio importante.
Presentado el 2026-08-14
via SEC EDGAR
Historial de Resultados
via SEC EDGAR
Latest News
Recent headlines for RDNT, sourced from Markets Gazette.
- 3/2/2026NEUTRALRadNet (RDNT) Q4 2025 Earnings Call Transcript
The transcript for RadNet Inc.'s (RDNT) Q4 2025 earnings call is now available to investors. While access to such documents is crucial for understanding the company's financial performance and future outlook, the current lack of specific content details prevents an immediate assessment of market impact. Analysts and investors are awaiting a review of key data, management statements, and projections to evaluate RadNet's operational and strategic health. Earnings calls are pivotal moments for grasping growth trends, profit margins, and any potential challenges the company might face in the diagnostic imaging services sector. Without the content, the signal remains neutral, pending further insights.
- 3/2/2026NEUTRALRadNet Earnings Review: Q4 Summary
Markets Gazette notes the announcement of RadNet's Q4 earnings review. While the title suggests an upcoming analysis of the company's financial performance, the provided article lacks specific details regarding the results, such as revenue figures, earnings per share, or future projections. This absence of concrete data prevents investors from assessing RadNet's current financial health or anticipating potential market movements. Traders are eagerly awaiting further information to formulate informed investment strategies.
via Markets Gazette